Machine Learning
Excerpt from the article: “CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nuritas, a biotechnology company that is revolutionizing the discovery and use of therapeutic peptides through artificial intelligence (AI) and genomics, today announced that it has received a grant from Partnership for Advanced Computing in Europe (PRACE) to identify therapeutic peptides for the treatment of patients with COVID-19. Under the…
Read More
Excerpt from the article: “When it comes to viral outbreaks, every day is valuable: stopping a pandemic means getting the right information to the right people at the right time. BlueDot identified the emerging risk of COVID-19 in Hubei province eight days before the World Health Organization.” Click the button below to read the entire…
Read More
Researchers in the United States and China reported on Monday that they developed an artificial intelligence tool that is able to accurately predict which newly infected patients with the coronavirus go on to develop severe lung disease. Once deployed, the algorithm could assist doctors in making choices about where to prioritise care in resource-stretched healthcare…
Read More
Excerpt from the article: “AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical…
Read More
Excerpt from the Article: A newly developed artificial intelligence (AI)-based system is highly accurate for detecting the novel coronavirus disease (COVID-19) on thoracic CT studies, according to research published online March 13 on arXiv.org. It can also quantify and track disease burden. Click the button below to read the entire article: Continue Reading The Article
Read More
Excerpt from the article: “Researchers from China have developed an artificial intelligence (AI) algorithm that accurately detects COVID-19 and differentiates it from community-acquired pneumonia and other lung diseases. They shared their results in an article published online March 19 in Radiology.” Click the button below to read the entire article! Continue To The Article
Read More
The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program is Canada’s single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures. Application for the 2020 ONtrepreneurs Competition is NOW OPEN! Click the button below to read his entire Article! Continue To The Site To…
Read More
Meet with Christopher Kata, Director of Sales & Marketing March 17th to 18th, in Milwaukee, Wisconsin. Christopher is in town on business and has availability for additional meetings. Arrange to meet in person and learn how TrialStat is leading the way with their innovative, interoperable Electronic Data Capture (Data Management) platform. Learn how you can…
Read More
Meet with Christopher Kata, Director of Sales and Marketing March 3rd to 4th, San Diego, California. Christopher is in town for client meetings and has availability for additional meetings. Christopher Kata, Director of Sales & Marketing905 [email protected] Arrange to meet in person and learn how TrialStat is leading way in innovative, interoperable Electronic Data Capture…
Read More
We met incredible researchers, partners, and solution providers at the event, and thanks to our on the ground team Christopher Kata, Heather Williams, and Chris Hamelin, we were able to engage with them using our recently released eClinical Technology interoperability diagram that maps out TrialStat’s innovative advances in Trial Management Technology, Vendor Neutral Imaging Archive,…
Read More